Cite Filings / DNLI / 0001950047-25-005790
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

Denali Therapeutics Inc. · Filed 2025-08-13 · Acc 0001950047-25-005790

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2025-12-04 144 Sale of Securities
  • 2025-08-14 4 COFO and Secretary sold 2,937 shares at $13.58 ($39,884)
  • 2025-08-14 4 Chief Medical Officer sold 3,743 shares at an average $13.81 ($51,684)
  • 2025-08-13 144 Sale of Securities
  • 2025-08-12 144 Sale of Securities
  • 2025-08-12 144 Sale of Securities
  • 2025-08-12 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…